Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-68.43%Return on Equity
VS
Market
Sector
Industry
History
$ 1.67Close
$ 0.26 - $ 1.84 52-Week Range
Ticker Information
Ticker
OVIDCompany Name
OVID THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQOVID THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
OVID - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 55.79M | $ -38.18M | -68.43% |
| 3/31/2025 | $ 59.28M | $ -24.97M | -42.13% |
| 12/31/2024 | $ 68.23M | $ -26.43M | -38.74% |
| 9/30/2024 | $ 76.29M | $ -32.5M | -42.6% |
| 6/30/2024 | $ 88.9M | $ -29.75M | -33.46% |
| 3/31/2024 | $ 78.28M | $ -50.68M | -64.74% |
| 12/31/2023 | $ 87.8M | $ -52.34M | -59.61% |
| 9/30/2023 | $ 101.29M | $ -48.52M | -47.9% |
| 6/30/2023 | $ 110.7M | $ -49.24M | -44.48% |
| 3/31/2023 | $ 120.95M | $ -51.42M | -42.51% |
Key Performance Insights, Last 5 Years
- OVID THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -119.38%.
- Over the past 5 years, OVID THERAPEUTICS INC's average ROE has been -36.11%.
- The median ROE for OVID THERAPEUTICS INC during this period was -42.56%
- OVID THERAPEUTICS INC reached its highest ROE over the past 5 years at 68.34%.
- The lowest ROE recorded by OVID THERAPEUTICS INC in the same timeframe -185.73%
OVID THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for OVID THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -75.98M ] / Equity [ $ 63.64M ]
(=) ROE [ -119.38% ] OVID - Return on Equity, Last 5 years
-185.73%
Minimum
Dec 31, 2020
68.34%
Maximum
Dec 31, 2021
-36.11%
Average
-42.56%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |